Industry Pages™ is a free annual report produced by OCT Clinical for pharmaceutical industry experts.
It collates data from numerous public sources into a single brief document, the aim of which is to aid decision makers who are planning to conduct clinical trials in Eastern Europe. The Industry Pages report will enable readers to understand and gain insights into the clinical research market in Eastern Europe, along with its landscape, key players and emerging trends.
The U.S. Food and Drug Administration (FDA) published its Novel Drug Approvals Report for 2021. 33 out of 50 drugs underwent clinical trials in Eastern Europe. Read the annual Industry Pages report, prepared by OCT Clinical, a European CRO, to find out why global pharma considers the region as the best destination for their clinical research activities.
